GGrantIndex
← Search

Flow Cytometry and Immune Monitoring Shared Resource (FCIMSR)

$194,429P30FY2024CANIH

University Of Arizona, Tucson AZ

Investigators

Linked publications, trials & patents

Paper 39631050Paper 39622842Paper 39612086Paper 39361227Paper 39312766Paper 39151774Paper 39100646Paper 39075233Paper 38875929Paper 38858600Paper 38826434Paper 38804255Paper 38769192Paper 38759377Paper 38729260Paper 38719743Paper 38715255Paper 38687603Paper 38658768Paper 38639990Paper 38613866Paper 38612480Paper 38474232Paper 38464045Paper 38453918Paper 38386696Paper 38386396Paper 38328594Paper 38313301Paper 38309054Paper 38291312Paper 38215755Paper 38203706Paper 38199366Paper 38164625Paper 38164604Paper 38097734Paper 38097593Paper 38096366Trial NCT07214506Trial NCT06009926Trial NCT05699603Trial NCT05237960Trial NCT05121051Trial NCT04530552Trial NCT03708055Trial NCT03602066Trial NCT03601507Trial NCT03578432Trial NCT03422536Trial NCT03402230Trial NCT03376971Trial NCT03365895Trial NCT03196180Trial NCT02581137Trial NCT02568566Trial NCT02348203Trial NCT02326805Trial NCT02123849Trial NCT01686165Trial NCT01433913Trial NCT01394211Trial NCT01385280Trial NCT01370889Trial NCT01288261Trial NCT01172028Trial NCT01097304Trial NCT01077453Trial NCT00980395Trial NCT00978718Trial NCT00900432Trial NCT00900341Trial NCT00898703Trial NCT00896935Trial NCT00892268Trial NCT00841204Trial NCT00752739Trial NCT00732498Trial NCT00721877Trial NCT00702299Trial NCT00701857Trial NCT00699907Trial NCT00619060Trial NCT00608634Trial NCT00601640Trial NCT00410618Trial NCT00373022Trial NCT00363805Trial NCT00303823Trial NCT00245024Trial NCT00091325Trial NCT00078897Trial NCT00003307Trial NCT00003082Patent 9486545Patent 9435812Patent 9415110Patent 9262824Patent 5650489Patent 5510240

Abstract

FLOW CYTOMETRY & IMMUNE MONITORING: ABSTRACT The Flow Cytometry & Immune Monitoring Shared Resource (FCIMSR) has served investigators of the University of Arizona Cancer Center (UACC) for more than 30 years. With the establishment of new cutting- edge comprehensive immune monitoring services for basic and translational research, FCIMSR has been renamed from the previous Flow Cytometry Shared Resource to highlight the full breadth of services now available. The goal of FCIMSR is to offer UACC Members efficient and reliable flow cytometric and comprehensive immune monitoring services with a high standard of quality control and in a cost-effective manner. Led by Sara Centuori, PhD, and supported by three full-time staff, FCIMSR provides the knowledge and expertise necessary to design experiments, develop new assays, perform flow cytometric functions, and interpret data. FCIMSR is supported by chargebacks and UACC funding with the intent to prioritize cancer- related services to UACC Members. In CY20, FCIMSR was utilized by 83 unique users, 55% of which were UACC Members (86% with peer-reviewed extramural funding). The volume of FCIMSR usage has steadily increased since 2016, supporting 60 publications by UACC Members and 256 funded grant proposals. In response to UACC Member needs, FCIMSR expanded its breadth of services to include human immune monitoring in 2020. FCIMSR now houses a Cytek Aurora flow cytometer, an instrument capable of detecting 40 markers in one sample allowing for state-of-the-art multiparametric flow cytometry profiling and immune profiling capabilities. The Specific Aims of FCIMSR are focused on three pillars: Service, Education, and Collaboration. The short-term goals of FCIMSR are to increase knowledge of advanced flow cytometric and immune monitoring assays, provide and expand services offered in these areas, and encourage collaborations between FCIMSR and other UACC Shared Resources to meet UACC Member needs more efficiently and economically. The long-term goal and vision for this facility is to evolve as a well-established, comprehensive flow cytometric and immune monitoring facility, offering the latest and most innovative technologies to UACC Members in areas of both fundamental and translational cancer research.

View original record on NIH RePORTER →